Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer.
Shee K, Jiang A, Varn FS, Liu S, Traphagen NA, Owens P, Ma CX, Hoog J, Cheng C, Golub TR, Straussman R, Miller TW.
Shee K, et al. Among authors: jiang a.
FASEB J. 2019 Feb;33(2):1644-1657. doi: 10.1096/fj.201801241R. Epub 2018 Aug 30.
FASEB J. 2019.
PMID: 30161001
Free PMC article.
These findings highlight BMP4 and its downstream pathway activation as a therapeutic opportunity in ER(+) breast cancer.-Shee, K., Jiang, A., Varn, F. S., Liu, S., Traphagen, N. A., Owens, P., Ma, C. X., Hoog, J., Cheng, C., Golub, T. R., Straussman, R …
These findings highlight BMP4 and its downstream pathway activation as a therapeutic opportunity in ER(+) breast cancer.-Shee, K., …